Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-αβ/CD19-depleted haploidentical stem cell grafts

HLA-haploidentical stem cell transplantation after removal of   + T and B cells in children with nonmalignant disorders

(2014) A. Bertaina et al.   BLOOD

Modification of T Cell Responses by Stem Cell Mobilization Requires Direct Signaling of the T Cell by G-CSF and IL-10

(2014) K. P. A. MacDonald et al.   JOURNAL OF IMMUNOLOGY

"Designed" grafts for HLA-haploidentical stem cell transplantation

(2013) M. F. Martelli et al.   BLOOD

Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses

(2013) G. Nizzoli et al.   BLOOD

Characterization of peripheral blood stem cell grafts mobilized by granulocyte colony-stimulating factor and plerixafor compared with granulocyte colony-stimulating factor alone

(2013) Beatrice Gaugler et al.   CYTOTHERAPY

Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device

(2013) Michael Schumm et al.   CYTOTHERAPY

Differences in the Phenotype, Cytokine Gene Expression Profiles, and In Vivo Alloreactivity of T Cells Mobilized with Plerixafor Compared with G-CSF

(2013) A. Lundqvist et al.   JOURNAL OF IMMUNOLOGY

At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies

(2013) Franco Locatelli et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Addition of plerixafor for CD34+ cell mobilization in six healthy stem cell donors ensured satisfactory grafts for transplantation

(2013) Anne Werner Hauge et al.   TRANSFUSION

Toward a Refined Definition of Monocyte Subsets

(2013) Loems Ziegler-Heitbrock et al.   Frontiers in Immunology

Plerixafor Plus Granulocyte Colony-Stimulating Factor versus Placebo Plus Granulocyte Colony-Stimulating Factor for Mobilization of CD34+ Hematopoietic Stem Cells in Patients with Multiple Myeloma and Low Peripheral Blood CD34+ Cell Count: Results of a Subset Analysis of a Randomized Trial

(2012) Auayporn P. Nademanee et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia

(2012) G. L. Uy et al.   BLOOD

Transcript profiling of CD16-positive monocytes reveals a unique molecular fingerprint

(2012) Marion Frankenberger et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation

(2011) Franco Locatelli et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions

(2011) B. Foley et al.   BLOOD

How I treat patients who mobilize hematopoietic stem cells poorly

(2011) L. B. To et al.   BLOOD

Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?

(2011) M. Della Chiesa et al.   BLOOD

ISHAGE protocol: Are we doing it correctly?

(2011) Alison Whitby et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong Th17/Th1 T-cell responses

(2011) Anja Hänsel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells

(2011) A Dar et al.   LEUKEMIA

Nomenclature of monocytes and dendritic cells in blood

(2010) L. Ziegler-Heitbrock et al.   BLOOD

Successful mobilization of PBSCs in a healthy volunteer donor by addition of plerixafor after failure of mobilization with G-CSF alone

(2010) T Neumann et al.   BONE MARROW TRANSPLANTATION

Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors

(2010) Jérôme Cros et al.   IMMUNITY

Human CD141+(BDCA-3)+dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens

(2010) Sarah L. Jongbloed et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+cells as homologues of mouse CD8+dendritic cells

(2010) Annabell Bachem et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Effects of pegylated G-CSF on immune cell number and function in patients with gynecological malignancies

(2010) Giuseppina Bonanno et al.   Journal of Translational Medicine

Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma

(2009) John F. DiPersio et al.   JOURNAL OF CLINICAL ONCOLOGY

Plerixafor

(2009) John F. DiPersio et al.   NATURE REVIEWS DRUG DISCOVERY

Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction

(2008) S. M. Devine et al.   BLOOD